Gastroenterology
Volume 137, Issue 1 , Pages 119-128 , July 2009

Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding

  • Càndid Villanueva

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD o Ciberehd), Barcelona, Spain
    • Corresponding Author InformationReprint requests Address requests for reprints to: Dr Càndid Villanueva, Servei de Patologia Digestiva, Hospital de la Santa Creu i Sant Pau, Avgda. Sant Antoni M Claret, 167, 08025 Barcelona, Spain. fax: 34-93 556 56 08
    • ,
  • Carles Aracil

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • ,
  • Alan Colomo

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD o Ciberehd), Barcelona, Spain
    • ,
  • Virginia Hernández–Gea

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • ,
  • Josep M. López–Balaguer

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • ,
  • Cristina Alvarez–Urturi

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • ,
  • Xavier Torras

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD o Ciberehd), Barcelona, Spain
    • ,
  • Joaquim Balanzó

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD o Ciberehd), Barcelona, Spain
    • ,
  • Carlos Guarner

      Affiliations

    • Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Autonomous University, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD o Ciberehd), Barcelona, Spain

Received 19 July 2008 ,Accepted 17 March 2009.

References 

  1. D'Amico G, Garcia-Pagan JC, Luca A, et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611–1624
  2. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37:902–908
  3. Villanueva C, López-Balaguer JM, Aracil C, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol. 2004;40:757–765
  4. Thalheimer U, Mela M, Patch D, et al. Targeting portal pressure measurements: a critical reappraisal. Hepatology. 2004;39:286–290
  5. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–282
  6. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding- Unresolved issues (Summary of an American association for the study of liver diseases and European association for the study of liver single-topic conference). Hepatology. 2008;47:1764–1772
  7. Feu F, García-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–1059
  8. Villanueva C, Balanzó J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624–1629
  9. Hicken BL, Sharara AI, Abrams GA, et al. Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study. Aliment Pharmacol Ther. 2003;17:145–153
  10. Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey—the case for nonselective β-blockers. Gastroenterology. 2007;133:2029–2036
  11. Turnes J, Garcia-Pagan JC, Abraldes JG, et al. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol. 2006;101:506–512
  12. Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930–934
  13. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401–1407
  14. Villanueva C, Miñana J, Ortix J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345:647–655
  15. Villanueva C, Aracil C, Colomo A, et al. Nonselective β-blockers and hepatic venous pressure gradient monitoring: what lies behind nonresponse. Gastroenterology. 2008;134:1626–1627
  16. Garcia-Tsao G, Grace ND, Groszmann RJ, et al. Short-term effects of propranolol on portal pressure. Hepatology. 1986;6:101–106
  17. Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Portal Hypertension Collaborative Group Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–2261
  18. Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–488
  19. De BK, Sen S, Biswas PK, et al. Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotic in India: a hemodynamic evaluation. Am J Gastroenterol. 2000;95:2023–2028
  20. Vorobioff J, Picabea E, Villavicencio R, et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology. 1987;7:648–653
  21. Merkel C, Bolognesi M, Sacerdoti D, et al. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation. Aliment Pharmacol Ther. 2005;22:433–439
  22. Coltart DG, Shand DG. Plasma propranolol levels in the quantitive assessment of beta adrenergic blockade in man. Br Med J. 1970;3:731
  23. Evans GH, Shand DG. Disposition of propranolol: drug accumulation and steady state concentration during chronic oral administration in man. Clin Pharmacol Ther. 1973;14:48
  24. Valla D, Jiron MI, Poynard T, et al. Failure of hemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol. J Hepatol. 1987;5:144–148
  25. Shubrooks SJ, Zir LM, Dinsmore RE, et al. Left ventricular wall motion response to intravenous propranolol. Circulation. 1975;52:124–129
  26. De Madaira E, Palazon JM, Sánchez J, et al. Monitoring of HVPG during pharmacological therapy: a comparison between two methods. J Hepatol. 2005;42:79
  27. La Mura V, Abraldes JG, et al. Acute HVPG response to i.v. propranolol and risk of portal hypertension related bleeding. J Hepatol. 2007;46:S96–S97
  28. García-Pagán JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol. 2005;2:526–535
  29. De Franchis R. Evolving consensus in portal hypertension (Report of the Baveno III consensus workshop on methodology of diagnosis and therapy in portal hypertension). J Hepatol. 2005;43:167–176
  30. Garcia-Tsao G, Sanyal A, Grace ND, et al. Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938

 To view this article's video abstract, go to the AGA's YouTube Channel.

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported in part by a grant from the Fundació Investigació Sant Pau, and by a grant from the Instituto de Salud Carlos III (CO3/02) and by a grant of the Agència de Gestió d'Ajuts Universitaris i de Recerca (SGR05).

PII: S0016-5085(09)00509-5

doi: 10.1053/j.gastro.2009.03.048

Gastroenterology
Volume 137, Issue 1 , Pages 119-128 , July 2009

Article Tools

* Image Usage & Resolution